Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Chebi:28462
2. Ncgc00016987-01
3. Ajimalin (tn)
4. Ajmaline (jp17)
5. Dsstox_cid_25537
6. Dsstox_rid_80939
7. Dsstox_gsid_45537
8. Schembl18950
9. Ajmalan-17alpha,21alpha-diol
10. Chembl2357792
11. Hy-b1167
12. Tox21_110728
13. 4-formylphenyl4-formylbenzoate
14. Akos037515833
15. Cs-4769
16. Db01426
17. Cas-4360-12-7
18. D00199
19. Q385858
20. (1r,9r,10s,12r,13s,14r,16s,18r)-13-ethyl-8-methyl-8,15-diazahexacyclo[14.2.1.0^{1,9}.0^{2,7}.0^{10,15}.0^{12,17}]nonadeca-2,4,6-triene-14,18-diol
| Molecular Weight | 326.4 g/mol |
|---|---|
| Molecular Formula | C20H26N2O2 |
| XLogP3 | 1.8 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 326.199428076 g/mol |
| Monoisotopic Mass | 326.199428076 g/mol |
| Topological Polar Surface Area | 46.9 Ų |
| Heavy Atom Count | 24 |
| Formal Charge | 0 |
| Complexity | 570 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
For use as an antiarrhythmic agent.
Ajmaline is a class 1A antiarrhythmic agent. By interfering with the sodium channels, this drug allows for improvement in abnormal rhythms of the heart
The class I antiarrhythmic agents interfere with the sodium channel. A class IA agent lengthens the action potential (right shift) which brings about improvement in abnormal heart rhythms. This drug in particular has a high affinity for the Nav 1.5 sodium channel.
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Ajmaline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ajmaline, including repackagers and relabelers. The FDA regulates Ajmaline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ajmaline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ajmaline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ajmaline supplier is an individual or a company that provides Ajmaline active pharmaceutical ingredient (API) or Ajmaline finished formulations upon request. The Ajmaline suppliers may include Ajmaline API manufacturers, exporters, distributors and traders.
click here to find a list of Ajmaline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ajmaline written confirmation (Ajmaline WC) is an official document issued by a regulatory agency to a Ajmaline manufacturer, verifying that the manufacturing facility of a Ajmaline active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ajmaline APIs or Ajmaline finished pharmaceutical products to another nation, regulatory agencies frequently require a Ajmaline WC (written confirmation) as part of the regulatory process.
click here to find a list of Ajmaline suppliers with Written Confirmation (WC) on PharmaCompass.
Ajmaline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ajmaline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ajmaline GMP manufacturer or Ajmaline GMP API supplier for your needs.
A Ajmaline CoA (Certificate of Analysis) is a formal document that attests to Ajmaline's compliance with Ajmaline specifications and serves as a tool for batch-level quality control.
Ajmaline CoA mostly includes findings from lab analyses of a specific batch. For each Ajmaline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ajmaline may be tested according to a variety of international standards, such as European Pharmacopoeia (Ajmaline EP), Ajmaline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ajmaline USP).
LOOKING FOR A SUPPLIER?
